Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Arch Therapeutics Inc
ARTHCurrent price
0.53 USD
0 USD (0.00%)
Last closed
0.6 USD
Company
www.archtherapeutics.com
ISIN
US03939W1099
Sector
Healthcare
Industry
Biotechnology
Exchange
OTCQB
Capitalization
3 333 270 USD
Yield for 12 month
-72.78 %
1Y
3Y
5Y
10Y
15Y
ARTH
Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. It develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease. The company's flagship products include AC5 advanced wound system and AC5 topical hemostat, which are intended for skin applications, such as management of complicated chronic wounds or acute surgical wounds. It is also involved in the development of AC5-G for gastrointestinal endoscopic procedures, and AC5-V and AC5 surgical hemostat for hemostasis inside the body. The company was founded in 2006 and is based in Framingham, Massachusetts. Address: 235 Walnut Street, Framingham, MA, United States, 01702
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
600 USDP/E ratio
–Dividend Yield
–Current Year
+75 724 USD
Last Year
+15 652 USD
Current Quarter
+30 913 USD
Last Quarter
+31 866 USD
Current Year
-2 439 USD
Last Year
-35 837 USD
Current Quarter
+9 834 USD
Last Quarter
+10 311 USD
Key Figures ARTH
1 year
3 years
5 years
10 years
EBITDA
-4 719 572 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-199.27 %
PEG Ratio
–
Return On Equity TTM
-4014.8 %
Wall Street Target Price
600 USD
Revenue TTM
148 163 USD
Book Value
-2.83 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
132.6 %
Dividend Yield
–
Gross Profit TTM
-35 837 USD
Earnings per share
-1.01 USD
Diluted Eps TTM
-1.01 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics ARTH
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ARTH
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:200
Payout Ratio
–
Last Split Date
18.01.2023
Dividend Date
–
Stock Valuation ARTH
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
0.0783
Enterprise Value Revenue
84.159
Price Sales TTM
22.4973
Enterprise Value EBITDA
-3.4359
Price Book MRQ
34.6063
Financials ARTH
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ARTH
For 52 weeks
0.39 USD
11 USD
50 Day MA
0.73 USD
Shares Short Prior Month
–
200 Day MA
2.37 USD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart